These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Will blocking the platelet save the diabetic? King SB; Mahmud E Circulation; 1999 Dec 21-28; 100(25):2466-8. PubMed ID: 10604881 [No Abstract] [Full Text] [Related]
16. Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors. Roe MT; Moliterno DJ J Thromb Thrombolysis; 1999 Jun; 7(3):247-57. PubMed ID: 10373718 [No Abstract] [Full Text] [Related]
17. The platelet, the patient, and periprocedural infarction during percutaneous transluminal coronary angioplasty. Fischman DL; Savage MP JAMA; 1997 Aug; 278(6):518-9. PubMed ID: 9256229 [No Abstract] [Full Text] [Related]
18. Angiographic predictors of adverse outcomes in the modern interventional era. White CJ J Am Coll Cardiol; 2003 Sep; 42(6):989-90. PubMed ID: 13678917 [No Abstract] [Full Text] [Related]
19. Platelet glycoprotein IIb/IIIa receptor blockers: An appropriate-use model for expediting care in acute coronary syndromes. Kereiakes DJ; McDonald M; Broderick T; Roth EM; Whang DD; Martin LH; Howard WL; Schneider J; Shimshak T; Abbottsmith CW Am Heart J; 2000 Feb; 139(2 Pt 2):S53-60. PubMed ID: 10650317 [No Abstract] [Full Text] [Related]
20. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. Topol EJ; Moliterno DJ; Herrmann HC; Powers ER; Grines CL; Cohen DJ; Cohen EA; Bertrand M; Neumann FJ; Stone GW; DiBattiste PM; Demopoulos L; N Engl J Med; 2001 Jun; 344(25):1888-94. PubMed ID: 11419425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]